Skip to main content

CTOS 2016

Randomized Phase 3, Multicenter, Open-Label Study Comparing Evofosfamide (EVO) in Combination with Doxorubicin (D) versus D Alone in Patients with Advanced Soft-Tissue Sarcoma (STS): Study TH-CR-406/SARC021

Conference Correspondent

Prognosis of Patients Receiving First-Line Chemotherapy for Advanced Soft-Tissue Sarcomas (STSs) with Locally Advanced vs Distant Metastasis vs Both: An EORTC-STBSG Database Analysis

Conference Correspondent

Real-Life Clinical Outcomes of Pazopanib Treatment in Patients with STS: A Japanese Musculoskeletal Oncology Group Study

Conference Correspondent

AXI-STS: A UK NCRI Sarcoma Clinical Studies Group Phase 2 Trial of Axitinib in Advanced STS

Conference Correspondent

Safety Profile of Trabectedin in Patients with Advanced Soft-Tissue Sarcoma (STS) Who Relapsed after Chemotherapy: Global Expanded Access Program Data

Conference Correspondent

Trabectedin Combined with Nivolumab in Advanced STS

Conference Correspondent

Trabectedin in Patients with Advanced Soft-Tissue Sarcoma (STS) Who Are Unfit for Standard Chemotherapy

Conference Correspondent

TRC105 (Endoglin Antibody) in Combination with Pazopanib in Patients with Advanced Angiosarcoma

Conference Correspondent

Meta-Analysis of Pazopanib versus Other Antiangiogenic Tyrosine Kinase Inhibitors (TKIs) in Advanced STS

Conference Correspondent

Pembrolizumab in Advanced Soft-Tissue Sarcomas (STS)

Conference Correspondent

Page 1 of 2

1
2